For your business
To view pricing and availability
To see product options, make selections below.
Adhesive |
|
Antimicrobial |
|
Applications and Size |
|
Area of Application |
|
Brand |
|
Dressing Change Frequency/Use |
|
Dressing Type |
|
Latex Free |
|
Length Inches |
|
Material |
|
Primary or Secondary Dressing |
|
Product Category |
|
Product Shape |
|
Product Type |
|
Retail Packaging |
|
Sterile |
|
UNSPSC |
|
Width Inches |
|
Wound Condition Type |
|
Opticell with Chytoform technology is the next generation of chronic wound care dressings. Chytoform gelling fiber is primarily composed of chitosan, a well-known biological material derived from crustacean shells. Chitosan’s unique chemistry, including a positive charge at physiological pH, has made it the center of much academic and clinical research(1-30).
Medline Opticell dressings are the first application of this advanced biological material for use in chronic wound care, but chitosan has been used in other healthcare applications (e.g., topical hemostat, treatment of surgical wounds and traumatic injuries and in dietary supplements) because of its unique properties.
When Opticell with Chytoform technology comes into contact with moisture, it transforms into a strong, absorbent and conformable gel that controls minor bleeding common in newly debrided wounds.
A recent study compared Opticell’s absorptive capabilities to those of our main competitors.*
Reference: *Lab testing data on file.
Opticell’s Chytoform technology wicks fluid only vertically, not laterally. This reduces the risk of periwound maceration because wound fluid is not able to migrate across the dressing to reach this vulnerable skin.
Opticell’s conformable and thin profile provides optimal contact with the wound. Other dressings with reinforced fibers, on the other hand, may exhibit a ridging effect that can limit wound contact.
|
|||||||||||||
|